awmsg logo



human normal immunoglobulin (Octagam 10%®)


Reference No. 3188

Publication date:
27/07/2016


Appraisal information

human normal immunoglobulin (Octagam 10%®) 100 mg/ml solution for infusion


Company: Octapharma AG
BNF category: Immunological products and vaccines
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: 26/07/2016

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

In the absence of a submission from the holder of the marketing authorisation, human normal immunoglobulin (Octagam 10%®) cannot be endorsed for use within NHS Wales for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP).
Statement of Advice (SOA)
Download